Home/ Stocks/ CNTB

Connect Biopharma Holdings Limited Ordinary Shares

CNTB XNAS

$0.73 +0.01 (+1.13%) ▲ 15-min delayed

Open

$0.75

High

$0.76

Low

$0.71

Volume

338.8K

Market Cap

$45.89M

About Connect Biopharma Holdings Limited Ordinary Shares

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 64 Website →

Related Market News

No specific coverage for CNTB yet. Check out our latest market news or earnings calendar.

Get CNTB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Connect Biopharma Holdings Limited Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.